2. Search Result
Search Result
Results for "

hallucinogenic effects

" in MedChemExpress (MCE) Product Catalog:

11

Inhibitors & Agonists

3

Natural
Products

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-153015
    AAZ-A 154

    		5-HT Receptor Neurological Disease
    AAZ-A 154 is a selective, competitive and non-hallucinogenic 5-HT2AR antagonist. AAZ-A 154 can promote neuronal growth and produce long-lasting beneficial behavioral effects in rodents .
    AAZ-A 154
  • HY-118796
    4-Hydroxy MET

    4-HO-MET; 4-Hydroxy-N-methyl-N-ethyltryptamine

    		 5-HT Receptor Neurological Disease
    4-Hydroxy MET (4-HO-MET) is a psychoactive tryptamine (NPS), a structural variant of the endogenous neurotransmitter serotonin. 4-Hydroxy MET has hallucinogenic effects, affecting mood, movement, and cognitive function .
    4-Hydroxy MET
  • HY-N2510
    Myristicin

    Myristicine

    		 5-HT Receptor EGFR ERK Apoptosis Bacterial Infection Neurological Disease Inflammation/Immunology Cancer
    Myristicine is an orally bioavailable serotonin receptor antagonist and weak monoamine oxidase (MAO) inhibitor. Myristicine also exerts anti-cancer effects on gastric cancer cells by inhibiting the EGFR/ERK signaling pathway. Myristicine is the main component of nutmeg essential oil and has anti-cancer, anti-proliferative, antibacterial, anti-inflammatory and apoptosis-inducing effects. Myristicine abuse can produce hallucinogenic effects, organ damage, etc .
    Myristicin
  • HY-N15291
    Divinatorin A

    		Others Neurological Disease
    Divinatorin A is a diterpenoid extracted from Salvia divinorum. Divinatorin A has hallucinogenic properties .
    Divinatorin A
  • HY-169841
    IHCH-7086

    		5-HT Receptor Neurological Disease
    IHCH-7086 is a β-arrestin-biased 5-HT2A serotonin receptor agonist (Ki: 12.59 nM). IHCH-7086 recruits β-arrestin through activation of 5-HT2A receptors, thereby removing hallucinogenic activity. IHCH-7086 improves depression-like behavior in mice without hallucinogenic effects .
    IHCH-7086
  • HY-153015B
    AAZ-A 154 hydrochloride

    		5-HT Receptor Neurological Disease
    AAZ-A 154 hydrochloride is a selective, competitive and non-hallucinogenic 5-HT2AR antagonist. AAZ-A 154 hydrochloride can promote neuronal growth and produce long-lasting beneficial behavioral effects in rodents .
    AAZ-A 154 hydrochloride
  • HY-153015D
    AAZ-A 154 mesylate

    		5-HT Receptor Neurological Disease
    AAZ-A 154 mesylate is a selective, competitive and non-hallucinogenic 5-HT2AR antagonist. AAZ-A 154 mesylate can promote neuronal growth and produce long-lasting beneficial behavioral effects in rodents .
    AAZ-A 154 mesylate
  • HY-153015C
    AAZ-A 154 benzoate

    		5-HT Receptor Neurological Disease
    AAZ-A 154 benzoate is a selective, competitive and non-hallucinogenic 5-HT2AR antagonist. AAZ-A 154 benzoate can promote neuronal growth and produce long-lasting beneficial behavioral effects in rodents .
    AAZ-A 154 benzoate
  • HY-153015A
    AAZ-A 154 hydrobromide

    		5-HT Receptor Neurological Disease
    AAZ-A 154 hydrobromide is a selective, competitive and non-hallucinogenic 5-HT2AR antagonist. AAZ-A 154 hydrobromide can promote neuronal growth and produce long-lasting beneficial behavioral effects in rodents .
    AAZ-A 154 hydrobromide
  • HY-135222
    MMAI hydrochloride

    5-Methoxy-6-methyl-2-aminoindan hydrochloride

    		 5-HT Receptor Neurological Disease
    MMAI (5-Methoxy-6-methyl-2-aminoindan) hydrochloride is a selective serotonin releaser that does not produce psychoactive or hallucinogenic effects in the context of drug discrimination in rats. MMAI hydrochloride induces a behavioral syndrome in rats, including hypokinesia with freezing, spinning, Straub tail, flat posture, and reduced sleep time .
    MMAI hydrochloride
  • HY-N2510R
    Myristicin (Standard)

    		5-HT Receptor EGFR ERK Apoptosis Bacterial Infection Neurological Disease Inflammation/Immunology Cancer
    Myristicin (Standard) is the analytical standard of Myristicin. This product is intended for research and analytical applications. Myristicine is an orally bioavailable serotonin receptor antagonist and weak monoamine oxidase (MAO) inhibitor. Myristicine also exerts anti-cancer effects on gastric cancer cells by inhibiting the EGFR/ERK signaling pathway. Myristicine is the main component of nutmeg essential oil and has anti-cancer, anti-proliferative, antibacterial, anti-inflammatory and apoptosis-inducing effects. Myristicine abuse can produce hallucinogenic effects, organ damage, etc .
    Myristicin (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: